炎症生物标志物与1型和2型糖尿病抑郁症状改善:与抑郁症状集群的差异关联
本研究前瞻性合并三项研究数据,纳入332例1型糖尿病和189例2型糖尿病患者,评估76种基线炎症生物标志物与1年抑郁症状变化(CES-D量表)的关联。2型糖尿病中26种标志物水平较高与抑郁症状更大程度减轻相关,1型糖尿病中13种标志物水平较高与抑郁症状较小程度减轻相关;33种标志物存在显著效应修饰。
要点
- 2型糖尿病中26种炎症标志物基线水平较高与1年抑郁症状更大程度减轻相关。
- 1型糖尿病中13种炎症标志物基线水平较高与1年抑郁症状更小程度减轻相关。
- 33种标志物存在糖尿病类型间显著效应修饰,提示不同炎症通路可能相关。
核心结论
- 2型糖尿病中多种炎症生物标志物基线水平较高与抑郁症状更大程度减轻相关,而1型糖尿病中则与更小程度减轻相关。
- 与抑郁症状集群的关联存在糖尿病类型特异性差异,提示不同炎症相关通路可能对抑郁治疗反应有意义。
研究设计与样本
- 前瞻性分析合并三项研究(DIAMOS、ECCE HOMO和DDCT)的数据。
- 共332例1型糖尿病和189例2型糖尿病患者完成基线和1年随访检查。
- 抑郁症状采用流行病学研究中心抑郁量表(CES-D)评估,基线76种血清炎症生物标志物水平与1年抑郁症状变化采用多元线性回归估计关联。
主要发现
- 2型糖尿病中,26种生物标志物水平较高与抑郁症状更大程度减轻相关(β=0.128至0.255;p<0.05)。
- 1型糖尿病中,13种生物标志物水平较高与抑郁症状更小程度减轻相关(β=-0.189至-0.094;p<0.05)。
- 33种生物标志物观察到显著效应修饰(pinteraction<0.05)。
- 2型糖尿病中的正向关联在认知-情感和快感缺失症状改善中最强,1型糖尿病中的反向关联在躯体症状改善中最强。
关键数值与推荐
- 2型糖尿病:26种生物标志物较高水平与抑郁症状更大程度减轻相关(β=0.128至0.255;p<0.05)。
- 1型糖尿病:13种生物标志物较高水平与抑郁症状更小程度减轻相关(β=-0.189至-0.094;p<0.05)。
- 33种生物标志物存在显著效应修饰(pinteraction<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: People with diabetes and depression show large heterogeneity in their response to depression treatment. This study aimed to identify biomarkers of subclinical inflammation that were associated with improvement of depressive symptoms in people with type 1 diabetes and type 2 diabetes. METHODS: The prospective analysis combined data from three studies (DIAMOS, ECCE HOMO and DDCT). A total of 332 people with type 1 diabetes and 189 people with type 2 diabetes completed both the baseline and 1 year follow-up examinations. Depressive symptoms were assessed using the Center for Epidemiological Studies depression scale (CES-D). Associations between baseline serum levels of 76 biomarkers of inflammation and 1 year changes in depressive symptoms were estimated using multiple linear regression. RESULTS: In people with type 2 diabetes, higher levels of 26 biomarkers were associated with greater reductions in depressive symptoms (β=0.128 to 0.255; p<0.05), whereas in people with type 1 diabetes, higher levels of 13 biomarkers were linked with lower reductions in depressive symptoms (β=-0.189 to -0.094; p<0.05). A significant effect modification was observed for 33 biomarkers (pinteraction<0.05). The positive associations in type 2 diabetes were strongest for improvements in cognitive-affective and anhedonia symptoms, while the inverse associations in type 1 diabetes were strongest for improvements in somatic symptoms. CONCLUSIONS/INTERPRETATION: Higher baseline levels of multiple biomarkers of inflammation were associated with greater depression reduction in type 2 diabetes but lower depression reduction in type 1 diabetes. There were also diabetes type-specific differences in the associations with symptom clusters of depression. This suggests that different inflammation-related pathways may be relevant for the response to depression treatment in people with type 1 diabetes or type 2 diabetes.
引用
- Herder C, Zhu A, Schmitt A, et al. Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters. Diabetologia. 2025. PMID: 40624224. doi:10.1007/s00125-025-06472-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。